Haemonetics Corporation announced FDA approval of the PerQseal Elite vascular closure system for large-bore arterial procedures ...
Penumbra, Inc. announced that the FDA has granted clearance for the treatment of deep vein thrombosis (DVT) to the company&rsqu ...
Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...
Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...
Endovascular Engineering, Inc. (E2), a developer of technology for venous thromboembolism, announced FDA 510(k) clearance for b ...
Six-month results from Esprit BTK PAS were reported in patients with chronic limb-threatening ischemia (CLTI) treated with the ...
Stryker Peripheral Vascular announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) ...
Results from the prospective, single-arm, multicenter POWER PAD II study demonstrated that the Pulse intravascular lithotripsy ...
At VIVA 2026, the Vascular InterVentional Advances conference, William A. Gray, MD, presented findings from a subgroup analysis ...
One-year results from the prospective, multicenter, single-arm PROMISE III trial evaluated transcatheter arterialization of the ...
A post hoc analysis of the randomized HI-PEITHO study examined potential predictors of major bleeding in patients with acute in ...
The ELEGANCE registry, which focuses on historically underrepresented populations to generate real-world evidence, evaluated en ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results